Condition
DiGeorge Anomaly
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
80.0%-7% vs avg
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
80.0%
-6.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
75%
3 of 4 completed with results
Key Signals
3 with results80% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 1 (3)
P 2 (1)
Trial Status
Completed4
Terminated1
Trial Success Rate
80.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT01220531Not ApplicableCompleted
Thymus Transplantation Safety-Efficacy
NCT00579709Phase 1Completed
Thymus Transplantation With Immunosuppression
NCT00849888Phase 1TerminatedPrimary
Serum-Free Thymus Transplantation in DiGeorge Anomaly
NCT00576836Phase 2CompletedPrimary
Thymus Transplantation Dose in DiGeorge #932
NCT00579527Phase 1CompletedPrimary
Phase I/II Thymus Transplantation With Immunosuppression #950
Showing all 5 trials